The use of mouse models for understanding the biology of down syndrome and aging

Current Gerontology and Geriatrics Research

Volumn 2012, Issue , 2012, Pages

  Vacano, Guido N ^a   Duval, Nathan ^a   Patterson, David ^a  

^a UNIVERSITY OF DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84858220895     PISSN: 16877063     EISSN: 16877071     Source Type: Journal    
DOI: 10.1155/2012/717315     Document Type: Review

References (156)

1. Roizen N. J., Patterson D., Down's syndrome Lancet 2003 361 9365 1281 1289 (Pubitemid 36428586)
2. Pant S. S., Moser H. W., Krane S. M., Hyperuricemia in Down's syndrome Journal of Clinical Endocrinology and Metabolism 1968 28 4 472 478
3. Campos C., Guzmn R., Lpez-Fernndez E., Casado., Urinary uric acid and antioxidant capacity in children and adults with Down syndrome Clinical Biochemistry 2010 43 3 228 233
4. Barnes T. S., Brodsky G. L., Barela G. J., Bleskan J. H., Patterson D., Development of a mouse model for the study of human purine metabolism Advances in Experimental Medicine and Biology 1995 370 517 522
5. van der Wilt C. L., Backus H. H. J., Smid K., Comijn L., Veerman G., Wouters D., Voorn D. A., Priest D. G., Bunni M. A., Mitchell F., Jackman A. L., Jansen G., Peters G. J., Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors Cancer Research 2001 61 9 3675 3681 (Pubitemid 32694979)
6. Patterson D., Folate metabolism and the risk of Down syndrome Down's Syndrome, Research and Practice 2008 12 2 93 97
7. Copped F., Grossi E., Migheli F., Migliore L., Polymorphisms in folate-metabolizing genes, chromosome damage, and risk of Down syndrome in Italian women: identification of key factors using artificial neural networks BMC Medical Genomics 2010 3, article 42
8. Locke A. E., Dooley K. J., Tinker S. W., Cheong S. Y., Feingold E., Allen E. G., Freeman S. B., Torfs C. P., Cua C. L., Epstein M. P., Wu M. C., Lin X., Capone G., Sherman S. L., Bean L. J. H., Variation in folate pathway genes contributes to risk of congenital heart defects among individuals with Down syndrome Genetic Epidemiology 2010 34 6 613 623
9. Selhub J., Troen A., Rosenberg I. H., B vitamins and the aging brain Nutrition Reviews 2010 68 2 s112 s118
10. Patterson D., Cabelof D. C., Down syndrome as a model of DNA polymerase beta haploinsufficiency and accelerated aging. Mechanisms of Ageing and Development. In press
11. Munke M., Kraus J. P., Ohura T., Francke U., The gene for cystathionine -synthase (CBS) maps to the subtelomeric region on human chromosome 21q and to proximal mouse chromosome 17 American Journal of Human Genetics 1988 42 4 550 559
12. Miles E. W., Kraus J. P., Cystathionine -synthase: structure, function, regulation, and location of homocystinuria-causing mutations Journal of Biological Chemistry 2004 279 29 29871 29874 (Pubitemid 38937904)
13. Yang-Feng T. L., Ma Y. Y., Liang R., Prasad P. D., Leibach F. H., Ganapathy V., Assignment of the human folate transporter gene to chromosome 21q22.3 by somatic cell hybrid analysis and in situ hybridization Biochemical and Biophysical Research Communications 1995 210 3 874 879
14. Gregers J., Christensen I. J., Dalhoff K., Lausen B., Schroeder H., Rosthoej S., Carlsen N., Schmiegelow K., Peterson C., The association of reduced folate carrier 80 GA polymorphism to outcome in childhood acute lymphoblastic leukemia interacts with chromosome 21 copy number Blood 2010 115 23 4671 4677
15. Taub J. W., Ge Y., Down syndrome, drug metabolism, and chromosome 21 Pediatric Blood and Cancer 2005 44 1 33 39 (Pubitemid 39602563)
16. Butler C., Knox A. J., Bowersox J., Forbes S., Patterson D., The production of transgenic mice expressing human cystathionine beta-synthase to study Down syndrome Behavior Genetics 2006 36 3 429 438 (Pubitemid 43876781)
17. Maclean K. N., Sikora J., Koich V., Jiang H., Greiner L. S., Kraus E., Krijt J., Overdier K. H., Collard R., Brodsky G. L., Meltesen L., Crnic L. S., Allen R. H., Stabler S. P., Elleder M., Rozen R., Patterson D., Kraus J. P., A novel transgenic mouse model of CBS-deficient homocystinuria does not incur hepatic steatosis or fibrosis and exhibits a hypercoagulative phenotype that is ameliorated by betaine treatment Molecular Genetics and Metabolism 2010 101 2-3 153 162
18. Patterson D., Graham C., Cherian C., Matherly L. H., A humanized mouse model for the reduced folate carrier Molecular Genetics and Metabolism 2008 93 2 95 103
19. Sturgeon X., Gardiner K. J., Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions Mammalian Genome 2011 22 5-6 261 271
20. Davisson M. T., Schmidt C., Akeson E. C., Patterson D., Epstein C. J., Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome Molecular Genetics of Chromosome 21 and Down Syndrome 1990 New York, NY, USA Wiley-Liss 263 280
21. Gropp A., Giers D., Kolbus U., Trisomy in the fetal backcross progeny of male and female metacentric heterozygotes of the mouse. I Cytogenetics and Cell Genetics 1974 13 6 511 535
22. Epstein C. J., de la Cruz F. F., Gerald P. S., Animal models for autosomal trisomy Trisomy 21 (Down Syndrome) 1981 Baltimore, Md, USA University Park Press 263 273
23. Cox D. R., Epstein L. B., Epstein C. J., Genes coding for sensitivity to interferon (IfRec) and soluble superoxide dismutase (SOD-1) are linked in mouse and man and map to mouse chromosome 16 Proceedings of the National Academy of Sciences of the United States of America 1980 77 4 2168 2172 (Pubitemid 10089619)
24. Tan Y. H., Tischfield J., Ruddle F. H., The linkage of genes for the human interferon-induced antiviral protein and indophenol oxidase-B traits to chromosome G-21 Journal of Experimental Medicine 1973 137 2 317 330
25. Moore E. E., Jones C., Kao F. T., Oates D. C., Synteny between glycinamide ribonucleotide synthetase and superoxide dismutase (soluble) American Journal of Human Genetics 1977 29 4 389 396 (Pubitemid 8148064)
26. Arriagada C., Bustamante M., Atwater I., Rojas E., Caviedes R., Caviedes P., Apoptosis is directly related to intracellular amyloid accumulation in a cell line derived from the cerebral cortex of a trisomy 16 mouse, an animal model of Down syndrome Neuroscience Letters 2010 470 1 81 85
27. Bambrick L. L., Fiskum G., Mitochondrial dysfunction in mouse trisomy 16 brain Brain Research 2008 1188 1 9 16 (Pubitemid 350296061)
28. Gardiner K. J., Molecular basis of pharmacotherapies for cognition in Down syndrome Trends in Pharmacological Sciences 2010 31 2 66 73
29. Yu T., Li Z., Jia Z., Clapcote S. J., Liu C., Li S., Asrar S., Pao A., Chen R., Fan N., Carattini-Rivera S., Bechard A. R., Spring S., Henkelman R. M., Stoica G., Matsui S. I., Nowak N. J., Roder J. C., Chen C., Bradley A., Yu Y. E., A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions Human Molecular Genetics 2010 19 14 2780 2791
30. Duchon A., Raveau M., Chevalier C., Nalesso V., Sharp A. J., Herault Y., Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling down syndrome Mammalian Genome 2011 22 11-12 674 684
31. Reinholdt L. G., Ding Y., Gilbert G. T., Czechanski A., Solzak J. P., Roper R. J., Johnson M. T., Donahue L. R., Lutz C., Davisson M. T., Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn Mammalian Genome 2011 22 11-12 685 691
32. Hecht F., Case M. P., Lovrien E. W., Higgins J. V., Thuline H. C., Melnyk J., Nonrandomness of translocations in man: preferential entry of chromosomes into 1315/21 translocations Science 1968 161 3839 371 372
33. Williams J. D., Summitt R. L., Martens P. R., Kimbrell R. A., Familial Down syndrome due to t(10;21) translocation: evidence that the Down phenotype is related to trisomy of a specific segment of chromosome 21 American Journal of Human Genetics 1975 27 4 478 485
34. Polani P. E., Briggs J. H., Ford C. E., Clarke C. M., Berg J. M., A Mongol girl with 46 chromosomes The Lancet 1960 1 7127 721 724
35. Jenkins M. B., Boyd L., Reciprocal translocation, 4q-; 21p+, giving rise to Down's syndrome Journal of Medical Genetics 1976 13 4 323 326
36. Hill C. A., Sussan T. E., Reeves R. H., Richtsmeier J. T., Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic Down syndrome mice American Journal of Medical Genetics, Part A 2009 149 10 2158 2165
37. Williams A. D., Mjaatvedt C. H., Moore C. S., Characterization of the cardiac phenotype in neonatal Ts65Dn mice Developmental Dynamics 2008 237 2 426 435 (Pubitemid 351312115)
38. Kirsammer G., Jilani S., Liu H., Davis E., Gurbuxani S., Le Beau M. M., Crispino J. D., Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome Blood 2008 111 2 767 775
39. Blazek J. D., Gaddy A., Meyer R., Roper R. J., Li J., Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice Bone 2011 48 2 275 280
40. Baek K. H., Zaslavsky A., Lynch R. C., Britt C., Okada Y., Siarey R. J., Lensch M. W., Park I. H., Yoon S. S., Minami T., Korenberg J. R., Folkman J., Daley G. Q., Aird W. C., Galdzicki Z., Ryeom S., Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1 Nature 2009 459 7250 1126 1130
41. Yang A., Reeves R. H., Increased survival following tumorigenesis in Ts65Dn mice that model down syndrome Cancer Research 2011 71 10 3573 3581
42. Holtzman D. M., Santucci D., Kilbridge J., Chua-Couzens J., Fontana D. J., Daniels S. E., Johnson R. M., Chen K., Sun Y., Carlson E., Alleva E., Epstein C. J., Mobley W. C., Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome Proceedings of the National Academy of Sciences of the United States of America 1996 93 23 13333 13338 (Pubitemid 26382816)
43. Reeves R. H., Irving N. G., Moran T. H., Wohn A., Kitt C., Sisodia S. S., Schmidt C., Bronson R. T., Davisson M. T., A mouse model for Down syndrome exhibits learning and behaviour deficits Nature Genetics 1995 11 2 177 184
44. Choi J. H. K., Berger J. D., Mazzella M. J., Morales-Corraliza J., Cataldo A. M., Nixon R. A., Ginsberg S. D., Levy E., Mathews P. M., Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model Journal of Neurochemistry 2009 110 6 1818 1827
45. Kern D. S., Maclean K. N., Jiang H., Synder E. Y., Sladek J. R., Bjugstad K. B., Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn down syndrome mice Cell Transplantation 2011 20 3 371 379
46. Levine S., Saltzman A., Levy E., Ginsberg S. D., Systemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease Experimental and Molecular Pathology 2009 86 1 18 22
47. Costa A. C. S., Scott-McKean J. J., Stasko M. R., Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test Neuropsychopharmacology 2008 33 7 1624 1632 (Pubitemid 351684704)
48. Rueda N., Llorens-Martn M., Flrez J., Valdizn E., Banerjee P., Trejo J. L., Martnez-Cué C., Memantine normalizes several phenotypic features in the Ts65Dn mouse model of down syndrome Journal of Alzheimer's Disease 2010 21 1 277 290
49. Lockrow J., Boger H., Gerhardt G., Aston-Jones G., Bachman D., Granholm A. C., A noradrenergic lesion exacerbates neurodegeneration in a down syndrome mouse model Journal of Alzheimer's Disease 2011 23 3 471 489
50. Netzer W. J., Powell C., Nong Y., Blundell J., Wong L., Duff K., Flajolet M., Greengard P., Lowering beta-amyloid levels rescues learning and memory in a Down syndrome mouse model PloS one 2010 5 6
51. Lockrow J., Prakasam A., Huang P., Bimonte-Nelson H., Sambamurti K., Granholm A. C., Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model Experimental Neurology 2009 216 2 278 289
52. Shichiri M., Yoshida Y., Ishida N., Hagihara Y., Iwahashi H., Tamai H., Niki E., -Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome Free Radical Biology and Medicine 2011 50 12 1801 1811
53. Sano M., Ernesto C., Thomas R. G., Klauber M. R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C. W., Pfeiffer E., Schneider L. S., Thal L. J., A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease New England Journal of Medicine 1997 336 17 1216 1222 (Pubitemid 27183651)
54. Isaac M. G. E. K. N., Quinn R., Tabet N., Vitamin E for Alzheimer's disease and mild cognitive impairment Cochrane Database of Systematic Reviews 2008 3 CD002854
55. Lloret A., Bada M.-C., Mora N. J., Pallard F. V., Alonso M. D., Via J., Vitamin e paradox in alzheimer's disease: it does not prevent loss of cognition and may even be detrimental Journal of Alzheimer's Disease 2009 17 1 143 149
56. Brewer G. J., Why vitamin e therapy fails for treatment of Alzheimer's disease Journal of Alzheimer's Disease 2010 19 1 27 30
57. Moon J., Chen M., Gandhy S. U., Strawderman M., Levitsky D. A., Maclean K. N., Strupp B. J., Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of down syndrome Behavioral Neuroscience 2010 124 3 346 361
58. Meck W. H., Smith R. A., Williams C. L., Organizational changes in cholinergic activity and enhanced visuospatial memory as a function of choline administered prenatally or postnatally or both Behavioral Neuroscience 1989 103 6 1234 1241 (Pubitemid 20079151)
59. Meck W. H., Williams C. L., Metabolic imprinting of choline by its availability during gestation: implications for memory and attentional processing across the lifespan Neuroscience and Biobehavioral Reviews 2003 27 4 385 399 (Pubitemid 36999837)
60. Mehedint M. G., Craciunescu C. N., Zeisel S. H., Maternal dietary choline deficiency alters angiogenesis in fetal mouse hippocampus Proceedings of the National Academy of Sciences of the United States of America 2010 107 29 12834 12839
61. Craciunescu C. N., Johnson A. R., Zeisel S. H., Dietary choline reverses some, but not all, effects of folate deficiency on neurogenesis and apoptosis in fetal mouse brain Journal of Nutrition 2010 140 6 1162 1166
62. Costa A. C. S., Stasko M. R., Schmidt C., Davisson M. T., Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6brd1 Behavioural Brain Research 2010 206 1 52 62
63. Villar A. J., Belichenko P. V., Gillespie A. M., Kozy H. M., Mobley W. C., Epstein C. J., Identification and characterization of a new Down syndrome model, Ts[Rb(12.1716)]2Cje, resulting from a spontaneous Robertsonian fusion between T(1716)65Dn and mouse Chromosome 12 Mammalian Genome 2005 16 2 79 90 (Pubitemid 40895684)
64. Moore C. S., Hawkins C., Franca A., Lawler A., Devenney B., Das I., Reeves R. H., Increased male reproductive success in Ts65Dn Down syndrome mice Mammalian Genome 2011 21 11-12 543 549
65. Laffaire J., Rivals I., Dauphinot L., Pasteau F., Wehrle R., Larrat B., Vitalis T., Moldrich R. X., Rossier J., Sinkus R., Herault Y., Dusart I., Potier M. C., Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development BMC Genomics 2009 10, article 138 10138
66. Ishihara K., Amano K., Takaki E., Shimohata A., Sago H., Epstein C. J., Yamakawa K., Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of down syndrome Cerebral Cortex 2010 20 5 1131 1143
67. Sago H., Carlson E. J., Smith D. J., Kilbridge J., Rubin E. M., Mobley W. C., Epstein C. J., Huang T. T., Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities Proceedings of the National Academy of Sciences of the United States of America 1998 95 11 6256 6261 (Pubitemid 28248999)
68. Belichenko P. V., Kleschevnikov A. M., Salehi A., Epstein C. J., Mobley W. C., Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships Journal of Comparative Neurology 2007 504 4 329 345 (Pubitemid 47437199)
69. Shukkur E. A., Shimohata A., Akagi T., Yu W., Yamaguchi M., Murayama M., Chui D., Takeuchi T., Amano K., Subramhanya K. H., Hashikawa T., Sago H., Epstein C. J., Takashima A., Yamakawa K., Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome Human Molecular Genetics 2006 15 18 2752 2762 (Pubitemid 44400402)
70. Harrison D. E., Strong R., Sharp Z. D., Nelson J. F., Astle C. M., Flurkey K., Nadon N. L., Wilkinson J. E., Frenkel K., Carter C. S., Pahor M., Javors M. A., Fernandez E., Miller R. A., Rapamycin fed late in life extends lifespan in genetically heterogeneous mice Nature 2009 460 7253 392 395
71. Miller R. A., Harrison D. E., Astle C. M., Baur J. A., Boyd A. R., De Cabo R., Fernandez E., Flurkey K., Javors M. A., Nelson J. F., Orihuela C. J., Pletcher S., Sharp Z. D., Sinclair D., Starnes J. W., Wilkinson J. E., Nadon N. L., Strong R., Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice Journals of GerontologySeries A Biological Sciences and Medical Sciences 2011 66 A 2 191 201
72. Troca-Marn J. A., Alves-Sampaio A., Montesinos M. L., An increase in basal BDNF provokes hyperactivation of the Akt-Mammalian target of rapamycin pathway and deregulation of local dendritic translation in a mouse model of down's syndrome Journal of Neuroscience 2011 31 26 9445 9455
73. Korbel J. O., Tirosh-Wagner T., Urban A. E., Chen X. N., Kasowski M., Dai L., Grubert F., Erdman C., Gao M. C., Lange K., Sobel E. M., Barlow G. M., Aylsworth A. S., Carpenter N. J., Clark R. D., Cohen M. Y., Doran E., Falik-Zaccai T., Lewin S. O., Lott I. T., McGillivray B. C., Moeschler J. B., Pettenati M. J., Pueschel S. M., Rao K. W., Shaffer L. G., Shohat M., Van Riper A. J., Warburton D., Weissman S., Gerstein M. B., Snyder M., Korenberg J. R., The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies Proceedings of the National Academy of Sciences of the United States of America 2009 106 29 12031 12036
74. Korenberg J. R., Kawashima H., Pulst S. M., Ikeuchi T., Ogasawara N., Yamamoto K., Schonberg S. A., West R., Allen L., Magenis E., Ikawa K., Taniguchi N., Epstein C. J., Molecular definition of a region of chromosome 21 that causes features of the down syndrome phenotype American Journal of Human Genetics 1990 47 2 236 246
75. Olson L. E., Richtsmeier J. T., Leszl J., Reeves R. H., A chromosome 21 critical region does not cause specific down syndrome phenotypes Science 2004 306 5696 687 690 (Pubitemid 39440917)
76. Olson L. E., Roper R. J., Sengstaken C. L., Peterson E. A., Aquino V., Galdzicki Z., Siarey R., Pletnikov M., Moran T. H., Reeves R. H., Trisomy for the Down syndrome critical region is necessary but not sufficient for brain phenotypes of trisomic mice Human Molecular Genetics 2007 16 7 774 782 (Pubitemid 47061624)
77. Belichenko P. V., Kleschevnikov A. M., Masliah E., Wu C., Takimoto-Kimura R., Salehi A., Mobley W. C., Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of down syndrome Journal of Comparative Neurology 2009 512 4 453 466
78. Olson L. E., Mohan S., Bone density phenotypes in mice aneuploid for the Down syndrome critical region American Journal of Medical Genetics, Part A 2011 155 10 2436 2445
79. Pereira P. L., Magnol L., Sahn I., Brault V., Duchon A., Prandini P., Gruart A., Bizot J. C., Chadefaux-Vekemans B., Deutsch S., Trovero F., Delgado-Garca J. M., Antonarakis S. E., Dierssen M., Herault Y., A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome Human Molecular Genetics 2009 18 24 4756 4769
80. Head E., Lott I. T., Patterson D., Doran E., Haier R. J., Possible compensatory events in adult Down syndrome brain prior to the development of Alzheimer disease neuropathology: targets for nonpharmacological intervention Journal of Alzheimer's Disease 2007 11 1 61 76 (Pubitemid 46376710)
81. Yu T., Liu C., Belichenko P., Clapcote S. J., Li S., Pao A., Kleschevnikov A., Bechard A. R., Asrar S., Chen R., Fan N., Zhou Z., Jia Z., Chen C., Roder J. C., Liu B., Baldini A., Mobley W. C., Yu Y. E., Effects of individual segmental trisomies of human chromosome 21 syntenic regions on hippocampal long-term potentiation and cognitive behaviors in mice Brain Research 2010
82. Barlow G. M., Chen X. N., Shi Z. Y., Lyons G. E., Kurnit D. M., Celle L., Spinner N. B., Zackai E., Pettenati M. J., Van Riper A. J., Vekemans M. J., Mjaatvedt C. H., Korenberg J. R., Down syndrome congenital heart disease: a narrowed region and a candidate gene Genetics in Medicine 2001 3 2 91 101
83. Liu C., Morishima M., Yu T., Matsui S. I., Zhang L., Fu D., Pao A., Costa A. C., Gardiner K. J., Cowell J. K., Nowak N. J., Parmacek M. S., Liang P., Baldini A., Yu Y. E., Genetic analysis of Down syndrome-associated heart defects in mice Human Genetics 2011 130 5 623 632
84. O'Doherty A., Ruf S., Mulligan C., Hildreth V., Errington M. L., Cooke S., Sesay A., Modino S., Vanes L., Hernandez D., Linehan J. M., Sharpe P. T., Brandner S., Bliss T. V. P., Henderson D. J., Nizetic D., Tybulewicz V. L. J., Fisher E. M. C., Genetics: an aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes Science 2005 309 5743 2033 2037 (Pubitemid 41362316)
85. Reynolds L. E., Watson A. R., Baker M., Jones T. A., D'Amico G., Robinson S. D., Joffre C., Garrido-Urbani S., Rodriguez-Manzaneque J. C., Martino-Echarri E., Aurrand-Lions M., Sheer D., Dagna-Bricarelli F., Nizetic D., McCabe C. J., Turnell A. S., Kermorgant S., Imhof B. A., Adams R., Fisher E. M. C., Tybulewicz V. L. J., Hart I. R., Hodivala-Dilke K. M., Tumour angiogenesis is reduced in the Tc1 mouse model of Downs syndrome Nature 2010 465 7299 813 817
86. Oyama F., Cairns N. J., Shimada H., Oyama R., Titani K., Ihara Y., Down's syndrome: up-regulation of -amyloid protein precursor and mRNAs and their defective coordination Journal of Neurochemistry 1994 62 3 1062 1066 (Pubitemid 24064519)
87. Lyle R., Gehrig C., Neergaard-Henrichsen C., Deutsch S., Antonarakis S. E., Gene expression from the aneuploid chromosome in a trisomy mouse model of Down syndrome Genome Research 2004 14 7 1268 1274 (Pubitemid 39029223)
88. Seabrook G. R., Smith D. W., Bowery B. J., Easter A., Reynolds T., Fitzjohn S. M., Morton R. A., Zheng H., Dawson G. R., Sirinathsinghji D. J. S., Davies C. H., Collingridge G. L., Hilla R. G., Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein Neuropharmacology 1999 38 3 349 359 (Pubitemid 29097718)
89. Turner P. R., O'Connor K., Tate W. P., Abraham W. C., Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory Progress in Neurobiology 2003 70 1 1 32 (Pubitemid 36966639)
90. Priller C., Bauer T., Mitteregger G., Krebs B., Kretzschmar H. A., Herms J., Synapse formation and function is modulated by the amyloid precursor protein The Journal of Neuroscience 2006 26 27 7212 7221
91. Herzig M. C., Winkler D. T., Burgermeister P., Pfeifer M., Kohler E., Schmidt S. D., Danner S., Abramowski D., Strchler-Pierrat C., Brki K., Van Duinen S. G., Maat-Schieman M. L. C., Staufenbiel M., Mathews P. M., Jucker M., A is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis Nature Neuroscience 2004 7 9 954 960 (Pubitemid 39129504)
92. Salehi A., Delcroix J. D., Belichenko P. V., Zhan K., Wu C., Valletta J. S., Takimoto-Kimura R., Kleschevnikov A. M., Sambamurti K., Chung P. P., Xia W., Villar A., Campbell W. A., Kulnane L. S., Nixon R. A., Lamb B. T., Epstein C. J., Stokin G. B., Goldstein L. S. B., Mobley W. C., Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration Neuron 2006 51 1 29 42 (Pubitemid 43963336)
93. Simn A. M., Schiapparelli L., Salazar-Colocho P., Cuadrado-Tejedor M., Escribano L., Lpez de Maturana R., Del Ro J., Pérez-Mediavilla A., Frechilla D., Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to A levels Neurobiology of Disease 2009 33 3 369 378
94. Zigman W. B., Schupf N., Sersen E., Silverman W., Prevalence of dementia in adults with and without Down syndrome American Journal on Mental Retardation 1996 100 4 403 412 (Pubitemid 26047177)
95. Sleegers K., Brouwers N., Gijselinck I., Theuns J., Goossens D., Wauters J., Del-Favero J., Cruts M., Van Duijn C. M., Van Broeckhoven C., APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy Brain 2006 129 11 2977 2983 (Pubitemid 44684518)
96. Rovelet-Lecrux A., Hannequin D., Raux G., Le Meur N., Laquerrire A., Vital A., Dumanchin C., Feuillette S., Brice A., Vercelletto M., Dubas F., Frebourg T., Campion D., APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy Nature Genetics 2006 38 1 24 26 (Pubitemid 43011878)
97. Kasuga K., Shimohata T., Nishimura A., Shiga A., Mizuguchi T., Tokunaga J., Ohno T., Miyashita A., Kuwano R., Matsumoto N., Onodera O., Nishizawa M., Ikeuchi T., Identification of independent APP locus duplication in Japanese patients with early-onset Alzheimer disease Journal of Neurology, Neurosurgery and Psychiatry 2009 80 9 1050 1052
98. Ashe K. H., Zahs K. R., Probing the biology of Alzheimer's disease in mice Neuron 2010 66 5 631 645
99. Head E., Lott I. T., Down syndrome and beta-amyloid deposition Current Opinion in Neurology 2004 17 2 95 100 (Pubitemid 38446448)
100. Crews L., Rockenstein E., Masliah E., APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis Brain Structure and Function 2010 214 2-3 111 126
101. Elder G. A., Gama Sosa M. A., De Gasperi R., Transgenic mouse models of Alzheimer's disease Mount Sinai Journal of Medicine 2010 77 1 69 81
102. Fuentes J. J., Genesc L., Kingsbury T. J., Cunningham K. W., Pérez-Riba M., Estivill X., De La Luna S., DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways Human Molecular Genetics 2000 9 11 1681 1690 (Pubitemid 30427005)
103. Fuentes J. J., Pritchard M. A., Planas A. M., Bosch A., Ferrer I., Estivill X., A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart Human Molecular Genetics 1995 4 10 1935 1944
104. Ermak G., Morgan T. E., Davies K. J. A., Chronic overexpression of the calcineurin inhibitory gene DSCR1 (adapt78) is associated with Alzheimer's disease Journal of Biological Chemistry 2001 276 42 38787 38794
105. Shibasaki F., Hallin U., Uchino H., Calcineurin as a multifunctional regulator Journal of Biochemistry 2002 131 1 1 15 (Pubitemid 34137206)
106. Yang J., Rothermel B., Vega R. B., Frey N., McKinsey T. A., Olson E. N., Bassel-Duby R., Williams R. S., Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles Circulation Research 2000 87 12 E61 E68
107. Keating D. J., Dubach D., Zanin M. P., Yu Y., Martin K., Zhao Y. F., Chen C., Porta S., Arbonés M. L., Mittaz L., Pritchard M. A., DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease Human Molecular Genetics 2008 17 7 1020 1030 (Pubitemid 351426036)
108. Dierssen M., Arqué G., McDonald J., Andreu N., Martnez-Cué C., Flrez J., Fillat C., Behavioral characterization of a mouse model overexpressing DSCR1/RCAN1 PLoS ONE 2011 6 2
109. Cremona O., Di Paolo G., Wenk M. R., Lthi A., Kim W. T., Takei K., Daniell L., Nemoto Y., Shears S. B., Flavell R. A., McCormick D. A., De Camilli P., Essential role of phosphoinositide metabolism in synaptic vesicle recycling Cell 1999 99 2 179 188 (Pubitemid 29491784)
110. Suh B. C., Hille B., Regulation of ion channels by phosphatidylinositol 4,5-bisphosphate Current Opinion in Neurobiology 2005 15 3 370 378 (Pubitemid 40806451)
111. Di Paolo G., De Camilli P., Phosphoinositides in cell regulation and membrane dynamics Nature 2006 443 7112 651 657 (Pubitemid 44564702)
112. Harris T. W., Hartwieg E., Horvitz H. R., Jorgensen E. M., Mutations in synaptojanin disrupt synaptic vesicle recycling Journal of Cell Biology 2000 150 3 589 600
113. Di Paolo G., Moskowitz H. S., Gipson K., Wenk M. R., Voronov S., Obayashi M., Flavell R., Fitzsimonds R. M., Ryan T. A., De Camill P., Impaired Ptdlns(4,5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking Nature 2004 431 7007 415 422 (Pubitemid 39329574)
114. Arai Y., Ijuin T., Takenawa T., Becker L. E., Takashima S., Excessive expression of synaptojanin in brains with Down syndrome Brain and Development 2002 24 2 67 72 (Pubitemid 34224905)
115. Voronov S. V., Frere S. G., Giovedi S., Pollina E. A., Borel C., Zhang H., Schmidt C., Akeson E. C., Wenk M. R., Cimasoni L., Arancio O., Davisson M. T., Antonarakis S. E., Gardiner K., De Camilli P., Di Paolo G., Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome Proceedings of the National Academy of Sciences of the United States of America 2008 105 27 9415 9420
116. Berman D. E., Dall'Armi C., Voronov S. V., McIntire L. B. J., Zhang H., Moore A. Z., Staniszewski A., Arancio O., Kim T. W., Di Paolo G., Oligomeric amyloid- peptide disrupts phosphatidylinositol-4,5- bisphosphate metabolism Nature Neuroscience 2008 11 5 547 554 (Pubitemid 351595195)
117. Lott I. T., Head E., Down syndrome and alzheimer's disease: a link between development and aging Mental Retardation and Developmental Disabilities Research Reviews 2001 7 3 172 178 (Pubitemid 32843808)
118. Yang Q., Rasmussen S. A., Friedman J. M., Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study Lancet 2002 359 9311 1019 1025 (Pubitemid 34286539)
119. Seth A., Watson D. K., ETS transcription factors and their emerging roles in human cancer European Journal of Cancer 2005 41 16 2462 2478 (Pubitemid 41540623)
120. Dwyer J., Li H. E., Xu D., Lui J. P., Transcriptional regulation of telomerase activity: roles of the the ets transcription factor family Annals of the New York Academy of Sciences 2007 1114 36 47 (Pubitemid 350070389)
121. Baffico M., Perroni L., Rasore-Quartino A., Scartezzini P., Expression of the human ETS-2 oncogene in normal fetal tissues and in the brain of a fetus with trisomy 21 Human Genetics 1989 83 3 295 296 (Pubitemid 19250493)
122. Tymms M. J., Kola I., Regulation of gene expression by transcription factors Ets-1 and Ets-2 Molecular Reproduction and Development 1994 39 2 208 214 (Pubitemid 24312164)
123. Wolvetang E. J., Bradfield O. M., Hatzistavrou T., Crack P. J., Busciglio J., Kola I., Hertzog P. J., Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis Neurobiology of Disease 2003 14 3 349 356 (Pubitemid 37543514)
124. de Kerchove d'Exaerde A., Cartaud J., Ravel-Chapuis A., Seroz T., Pasteau F., Angus L. M., Jasmin B. J., Changeux J. P., Schaeffer L., Expression of mutant Ets protein at the neuromuscular synapse causes alterations in morphology and gene expression EMBO Reports 2002 3 11 1075 1081 (Pubitemid 35476836)
125. Sumarsono S. H., Wilson T. J., Tymms M. J., Venter D. J., Corrick C. M., Kola R., Lahoud M. H., Papas T. S., Seth A., Kola I., Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice Nature 1996 379 6565 534 537 (Pubitemid 26049578)
126. Wolvetang E. J., Wilson T. J., Sanij E., Busciglio J., Hatzistavrou T., Seth A., Hertzog P. J., Kola I., ETS2 overexpression in transgenic models and in Down sydrome predisposes to apoptosis via the p53 pathway Human Molecular Genetics 2003 12 3 247 255 (Pubitemid 36204422)
127. Okuda T., van Deursen J., Hiebert S. W., Grosveld G., Downing J. R., AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis Cell 1996 84 2 321 330 (Pubitemid 26042836)
128. Speck N. A., Gilliland D. G., Core-binding factors in haematopoiesis and leukaemia Nature Reviews Cancer 2002 2 7 502 513 (Pubitemid 37328932)
129. Hitzler J. K., Zipursky A., Origins of leukaemia in children with down syndrome Nature Reviews Cancer 2005 5 1 11 20 (Pubitemid 40052321)
130. Tassone F., Lucas R., Slavov D., Kavsan V., Crnic L., Gardiner K., Gene expression relevant to Down syndrome: problems and approaches Journal of Neural Transmission, Supplement 1999 57 179 195
131. Gjertson C., Sturm K. S., Berger C. N., Hematopoietic deficiencies and
132. McElwaine S., Mulligan C., Groet J., Spinelli M., Rinaldi A., Denyer G., Mensah A., Cavani S., Baldo C., Dagna-Bricarelli F., Hann I., Basso G., Cotter F. E., Nizetic D., Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Down's syndrome, revealing PRAME as a specific discriminating marker British Journal of Haematology 2004 125 6 729 742 (Pubitemid 38813599)
133. Yanagida M., Osato M., Yamashita N., Liqun H., Jacob B., Wu F., Cao X., Nakamura T., Yokomizo T., Takahashi S., Yamamoto M., Shigesada K., Ito Y., Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice Oncogene 2005 24 28 4477 4485 (Pubitemid 41032611)
134. Elagib K. E., Racke F. K., Mogass M., Khetawat R., Delehanty L. L., Goldfarb A. N., RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation Blood 2003 101 11 4333 4341 (Pubitemid 36857797)
135. Xu G., Nagano M., Kanezaki R., Toki T., Hayashi Y., Taketani T., Taki T., Mitui T., Koike K., Kato K., Imaizumi M., Sekine I., Ikeda Y., Hanada R., Sako M., Kudo K., Kojima S., Ohneda O., Yamamoto M., Ito E., Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome Blood 2003 102 8 2960 2968 (Pubitemid 37248871)
136. Mundschau G., Gurbuxani S., Gamis A. S., Greene M. E., Arceci R. J., Crispino J. D., Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis Blood 2003 101 11 4298 4300 (Pubitemid 36857792)
137. Hitzler J. K., Cheung J., Li Y., Scherer S. W., Zipursky A., GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome Blood 2003 101 11 4301 4304 (Pubitemid 36857793)
138. Ahmed M., Sternberg A., Hall G., Thomas A., Smith O., O'Marcaigh A., Wynn R., Stevens R., Addison M., King D., Stewart B., Gibson B., Roberts I., Vyas P., Natural history of GATA1 mutations in Down syndrome Blood 2004 103 7 2480 2489 (Pubitemid 38392997)
139. Osato M., Ito Y., Increased dosage of the RUNX1/AML1 gene: a third mode of RUNX leukemia? Critical Reviews in Eukaryotic Gene Expression 2005 15 3 217 228
140. Zheng H., Jiang M., Trumbauer M. E., Hopkins R., Sirinathsinghji D. J. S., Stevens K. A., Conner M. W., Slunt H. H., Sisodia S. S., Chen H. Y., Van Der Ploeg L. H. T., Mice deficient for the amyloid precursor protein gene Annals of the New York Academy of Sciences 1996 777 421 426 (Pubitemid 26149224)
141. Heber S., Herms J., Gajic V., Hainfellner J., Aguzzi A., Rulicke T., Kretzschmar H., Von Koch C., Sisodia S., Tremml P., Lipp H. P., Wolfer D. P., Muller U., Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members Journal of Neuroscience 2000 20 21 7951 7963
142. Cataldo A. M., Petanceska S., Peterhoff C. M., Terio N. B., Epstein C. J., Villar A., Carlson E. J., Staufenbiel M., Nixon R. A., App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of Down syndrome Journal of Neuroscience 2003 23 17 6788 6792 (Pubitemid 36951206)
143. Harrington A. W., St. Hillaire C., Zweifel L. S., Glebova N. O., Philippidou P., Halegoua S., Ginty D. D., Recruitment of actin modifiers to TrkA endosomes governs retrograde NGF signaling and survival Cell 2011 146 3 421 434
144. Vega R. B., Rothermel B. A., Weinheimer C. J., Kovacs A., Naseem R. H., Bassel-Duby R., Williams R. S., Olson E. N., Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy Proceedings of the National Academy of Sciences of the United States of America 2003 100 2 669 674 (Pubitemid 36126110)
145. Lange A. W., Rothermel B. A., Yutzey K. E., Restoration of DSCR1 to disomy in the trisomy 16 mouse model of Down syndrome does not correct cardiac or craniofacial development anomalies Developmental Dynamics 2005 233 3 954 963 (Pubitemid 40853471)
146. Loughran S. J., Kruse E. A., Hacking D. F., de Graaf C. A., Hyland C. D., Willson T. A., Henley K. J., Ellis S., Voss A. K., Metcalf D., Hilton D. J., Alexander W. S., Kile B. T., The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells Nature Immunology 2008 9 7 810 819 (Pubitemid 351859165)
147. Ng A. P., Hyland C. D., Metcalf D., Carmichael C. L., Loughran S. J., Di Rago L., Kile B. T., Alexander W. S., Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome Blood 2010 115 19 3966 3969
148. Henkel G. W., McKercher S. R., Yamamoto H., Anderson K. L., Oshima R. G., Maki R. A., PU.1 but not Ets-2 is essential for macrophage development from embryonic stem cells Blood 1996 88 8 2917 2926 (Pubitemid 26357372)
149. McCarthy S. A., Chen D., Yang B. S., Garcia Ramirez J. J., Cherwinski H., Chen X. R., Klagsbrun M., Hauser C. A., Ostrowski M. C., McMahon M., Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1 Molecular and Cellular Biology 1997 17 5 2401 2412 (Pubitemid 27175121)
150. Yamamoto H., Flannery M. L., Kupriyanov S., Pearce J., McKercher S. R., Henkel G. W., Maki R. A., Werb Z., Oshima R. G., Defective trophoblast function in mice with a targeted mutation of Ets2 Genes and Development 1998 12 9 1315 1326 (Pubitemid 28213407)
151. Man A. K., Young L. J. T., Tynan J. A., Lesperance J., Egeblad M., Werb Z., Hauser C. A., Muller W. J., Cardiff R. D., Oshima R. G., Ets2-dependent stromal regulation of mouse mammary tumors Molecular and Cellular Biology 2003 23 23 8614 8625 (Pubitemid 37433366)
152. Wei G., Srinivasan R., Cantemir-Stone C. Z., Sharma S. M., Santhanam R., Weinstein M., Muthusamy N., Man A. K., Oshima R. G., Leone G., Ostrowski M. C., Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis Blood 2009 114 5 1123 1130
153. Sussan T. E., Yang A., Li F., Ostrowski M. C., Reeves R. H., Trisomy represses ApcMin -mediated tumours in mouse models of Down's syndrome Nature 2008 451 7174 73 75
154. Jablonska B., Ford D., Trisler D., Pessac B., The growth capacity of bone marrow CD34 positive cells in culture is drastically reduced in a murine model of Down syndrome Comptes RendusBiologies 2006 329 9 726 732 (Pubitemid 44307948)
155. Lichtman M. A., Rowe J. M., The relationship of patient age to the pathobiology of the clonal myeloid diseases Seminars in Oncology 2004 31 2 185 197 (Pubitemid 38488832)
156. Carmichael C. L., Majewski I. J., Alexander W. S., Metcalf D., Hilton D. J., Hewitt C. A., Scott H. S., Hematopoietic defects in the Ts1Cje mouse model of Down syndrome Blood 2009 113 9 1929 1937